MorphoMed is a pre-clinical medical technology company developing next-generation orthopaedic implants based on silk biomaterials.
Our technology is designed to support the regeneration of both soft and hard tissues, addressing critical unmet needs in orthopaedics. We focus on solutions for tendon and ligament repair, as well as bone healing in large and medium bone defect cases where current treatment options remain limited.
By leveraging the unique mechanical and biological properties of silk, MorphoMed aims to create implants that promote natural tissue regeneration while integrating seamlessly with the body’s healing processes.
Currently in the pre-clinical development stage, we are preparing our first indication on Rotator Cuff Repair (RCR) with a primary focus on the U.S. market, guided by regulatory and clinical requirements.

MorphoMed GmbH

Org chart

Teams

Offices